Peer Review History

Original SubmissionJanuary 14, 2020
Decision Letter - Scott G. Filler, Editor

Dear Professor Ljungdahl,

Thank you very much for submitting your manuscript "Glutamate dehydrogenase (Gdh2)-dependent alkalization is dispensable for escape from macrophages and virulence of Candida albicans" (PPATHOGENS-D-20-00074) for consideration at PLOS Pathogens. As with all papers, your manuscript was reviewed by members of the editorial board. Based on our initial assessment, we regret that we will not be pursuing this manuscript for publication at PLOS Pathogens.

The consensus was that a significant limitation of the work is that the mutants were not shown to be alkalinization-defective after engulfment by macrophages. Without this critical control, it cannot be concluded definitively that alkalinization of the phagosome is dispensable for escape from macrophages and virulence of Candida albicans.

If you are able to address this issue, we would be happy to reconsider a revised version of the manuscript.

We are sorry that we cannot be more positive on this occasion. We very much appreciate your wish to present your work in one of PLOS's Open Access publications. Thank you for your support, and we hope that you will consider PLOS Pathogens for other submissions in the future.

Sincerely,

Scott Filler

Section Editor

PLOS Pathogens

Kasturi Haldar

Editor-in-Chief

PLOS Pathogens

orcid.org/0000-0001-5065-158X

Michael Malim

Editor-in-Chief

PLOS Pathogens

orcid.org/0000-0002-7699-2064

Revision 1

Attachments
Attachment
Submitted filename: Resub_Letter.pdf
Decision Letter - Scott G. Filler, Editor, Damian J Krysan, Editor

Dear Dr. Ljungdahl,

Thank you very much for submitting your manuscript "Glutamate dehydrogenase (Gdh2)-dependent alkalization is dispensable for escape from macrophages and virulence of Candida albicans" for consideration at PLOS Pathogens. As with all papers reviewed by the journal, your manuscript was reviewed by members of the editorial board and by several independent reviewers. In light of the reviews (below this email), we would like to invite the resubmission of a significantly-revised version that takes into account the reviewers' comments.

All three reviewer's indicated that direct measurement of the pH within the phagolysosome should be performed and I agree with this assessment.  If you decide to do this experiment, I think an important control is strains previously reported by the group with an alternative model.  This will insure that there are not some method or strain based idiosyncrasies responsible for the discordant results. I also feel that, in interests of collegiality, a discussion of possible reasons for the discordant conclusions would be helpful  As you will see there are a number of other important controls and data that need to be reported and I encourage you to give these points attention if you decide to revise the manuscript.

We cannot make any decision about publication until we have seen the revised manuscript and your response to the reviewers' comments. Your revised manuscript is also likely to be sent to reviewers for further evaluation.

When you are ready to resubmit, please upload the following:

[1] A letter containing a detailed list of your responses to the review comments and a description of the changes you have made in the manuscript. Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out.

[2] Two versions of the revised manuscript: one with either highlights or tracked changes denoting where the text has been changed; the other a clean version (uploaded as the manuscript file).

Important additional instructions are given below your reviewer comments.

Please prepare and submit your revised manuscript within 60 days. If you anticipate any delay, please let us know the expected resubmission date by replying to this email. Please note that revised manuscripts received after the 60-day due date may require evaluation and peer review similar to newly submitted manuscripts.

Thank you again for your submission. We hope that our editorial process has been constructive so far, and we welcome your feedback at any time. Please don't hesitate to contact us if you have any questions or comments.

Sincerely,

Damian J Krysan, MD PhD

Associate Editor

PLOS Pathogens

Scott Filler

Section Editor

PLOS Pathogens

Kasturi Haldar

Editor-in-Chief

PLOS Pathogens

orcid.org/0000-0001-5065-158X

Michael Malim

Editor-in-Chief

PLOS Pathogens

orcid.org/0000-0002-7699-2064

***********************

Reviewer's Responses to Questions

Part I - Summary

Please use this section to discuss strengths/weaknesses of study, novelty/significance, general execution and scholarship.

Reviewer #1: This manuscript describes a role for the C. albicans Glutamate dehydrogenase (Gdh2) in alkalization of the external environment, and surprisingly shows that this function is dispensable for escape from macrophages and virulence. This was unexpected because a previous model by Lorenz et al proposed that growth on amino acids in the phagosome would lead to ammonia release and alkalinization, which would stimulate hyphal growth and escape from the phagosome. Therefore, it was surprising that that deletion of GDH2, which prevented alkalinization in vitro, did not affect escape from macrophages or virulence. One strength of the manuscript is that the data provide strong support for a role for Gdh2 in alkalinization for cells grown on amino acids in vitro. This work also synergizes with previous work by this group of investigators showing that proline catabolism, which goes through Gdh2 and glutamate, is important for growth on amino acids and alkalinization. Another interesting conclusion was the demonstration that glucose could repress mitochondrial function, and GDH2 expression, preventing alkalization of the environment when amino acids were present. However, a weakness is that the pH of the phagosome was not measured. It is not clear if metabolism of other metabolites by gdh2 mutant cells still leads to alkalinization of the phagosome. For example, GlcNAc, alpha-ketoglutarate, and pyruvate have also been observed to contribute to alkalinization.

Reviewer #2: This manuscript describes an investigation of the factors required by C. albicans for alkalization of its environment. Alkalization of the phagosome environment upon engulfment of C. albicans has previously been hypothesised to induce the yeast to hyphal switch facilitating C. albicans escape from immune cells and therefore of high importance to pathogenicity.

Here, in agreement with a previous study (Westman et al, 2018), the authors show that alkalization is not required for hyphal induction inside the phagosome. The authors demonstrate that a mutant strain lacking Gdh2 glutamate dehydrogenase is defective in alkalization of a synthetic amino acid containing medium in contrast to wild type cells. GDh2-GFP was localised to mitochondria and expression was repressed in high concentrations of glucose but induced upon macrophage engulfment. The alkalization defect did not result in a morphogenesis defect in vitro and in macrophage co-culture assays. The ghd2 mutant was also virulent in a mouse and Drosophila infection models. In S. cerevisiae Ghd2 is also glucose –repressed and mitochondrial.

Reviewer #3: This manuscript characterized the role Candida albicans Gdh2 in alkalization under conditions of amino acids as a sole carbon source. The finding of a requirement for production of NH3 under these conditions in interesting, particularly as disruption has no impact on phagocytosis or virulence.

Strengths:

Inclusion of the GFP-strain to track Gdh2 to mitochondria

The inclusion of two animal models and multiple experiments to measure virulence

Most experiment use multiple lines of evidence

Limitations:

It is unclear gdh2 is responsible for NH3 production in the phagosome

It is unclear if disruption of gdh2 influences the phagosome pH.

**********

Part II – Major Issues: Key Experiments Required for Acceptance

Please use this section to detail the key new experiments or modifications of existing experiments that should be absolutely required to validate study conclusions.

Generally, there should be no more than 3 such required experiments or major modifications for a "Major Revision" recommendation. If more than 3 experiments are necessary to validate the study conclusions, then you are encouraged to recommend "Reject".

Reviewer #1: 1. The gdh2 mutant strain was not complemented by reintroduction of the wild type GDH2 gene. This control is especially important, considering that the authors come to a different conclusion than previous studies.

2. As mentioned above, the pH of the phagosome was not measured, so it is unclear if there are alternative pathways that can lead to alkalinization in the absence of GDH2.

3. Gdh2-GFP looks different in Figure 3A, than 2A. It looks cytoplasmic in Fig. 3A rather than mitochondrial. This raises questions about whether Fig. 3A is accurately reflecting the levels and localization of Gdh2.

Reviewer #2: A key experiment as set out in the authors’ covering letter is to show that the ghd2 mutant is incapable of alkalizing the macrophage phagosome. This will strengthen the evidence presented and clearly confirm the role of Ghd2 in this process in vivo ; reinforcing the in vitro measurements of pH changes presented in the manuscript.

Reviewer #3: Figure: 1C and 1D: For figure 1D, it appears that YNB +CAA +0.2% glucose was used from the text and should be included in the legend. It is not clear how well the gdh2 mutant grow in this media. If it is not growing well, this may impact NH3 production. A growth control should be used.

Line 302: Can the authors add data showing that the phagosome is or is not alkalinized when the gdh2 mutant is engulfed?

**********

Part III – Minor Issues: Editorial and Data Presentation Modifications

Please use this section for editorial suggestions as well as relatively minor modifications of existing data that would enhance clarity.

Reviewer #1: 1. The text should be modified to indicate that the lack of an essential role for in macrophage escape is not the same as saying it can’t contribute to escape along with other pathways.

2. In Figure 6, was the CFU assay done with macrophages infected with a single strain or mixed culture? If a WT and a gdh2-/- cell are in the same macrophage, the WT cell could alkalinize the phagosome and protect the gdh2-/- mutant.

3. It is not obvious that Gdh2-GFP is getting brighter in Figures SV1 SV2 and Figure 5. The level of Gdh2-GFP should be quantified to support the conclusion Gdh2 is induced.

4. The authors should comment on why there was only modest effect on growth of gdh2-/- mutant on proline in Fig. S1C? If Gdh2 is only partially necessary for growth on proline, does this indicate a gdh2-/- mutant could still contribute to alkalinization in a phagosome, albeit more weakly?

5. Does it matter which medium the C. albicans cells were grown in before they were used to infect macrophages? Residual carbon, nitrogen, and energy sources may dominate in the first stages of growth in the macrophage. This could make it more difficult to assess the role of Gdh2.

6. How was FITC staining done? Please provide additional information. E.g. was it crosslinked onto the cells? Taken up by endocytosis? The reason I am asking is that Figure 4B looks weird. The entire cell is stained. I was expecting new growth should not be stained if the FITC is cross-linked

7. Lines 172-174. This sentence should be clarified that Gdh2 is primarily, but not solely, responsible for ammonia production when cells were grown on glutamate.

Reviewer #2: Supplementary video 3 very rapidly goes out of focus so is not informative.

Line 192 strain

Line 200. Colonies were grown on solid……and the levels of volatile ammonia produced were measured.

Line 218 medium

Line 269 define NCR

Line 310 macrophages

Phagocytized and phagocytosed (line 325) both used in text, keep consistent

Reviewer #3: Figure S1: Why was the screen performed? Why were the mutants with the correct insertion not initially identified by PCR?

The authors should expand on how the growth media and conditions in the current study do or do not represent phagosome conditions.

Figure 2A: Include a glucose-rich condition.

Figure 2B: What is the impact of actimycin alone on the media? I assume that these experiments use the same pH indicator as 1B, but this should be added to the legend.

Lines 226-234: The description of the figure does not appear to match Figure 2. I don’t see right and left panels or the gdh2 mutant in Figure 2B.

Figure S2A: For the right panel, clarify the difference between Cm – and Cm 0. I assume that no organism was added to the Cm-, but this should be clarified.

Line 245: The authors should describe why different results were found for actimycin and chloramphenicol

Line 270: Clarify NCR

Figure 5A and B and supplemental video: Is there a peak fluorescence that is reached prior to the end of the experiment? If so, can the authors speculate as to why this is? Are the phagocytes dying and the glucose repression ending?

Line 337: Clarify the statement, as alkalization was not measured in the phagosome.

Line 378: The authors should avoid discussing the unpublished data, or include the data.

Line 448: Clarify if these conditions for filamentation were the same as the ones used in the current investigation and consider having a supplemental figure with the strains.

**********

PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

Reviewer #3: No

Figure Files:

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org.

Data Requirements:

Please note that, as a condition of publication, PLOS' data policy requires that you make available all data used to draw the conclusions outlined in your manuscript. Data must be deposited in an appropriate repository, included within the body of the manuscript, or uploaded as supporting information. This includes all numerical values that were used to generate graphs, histograms etc.. For an example see here on PLOS Biology: http://www.plosbiology.org/article/info%3Adoi%2F10.1371%2Fjournal.pbio.1001908#s5.

Reproducibility:

To enhance the reproducibility of your results, PLOS recommends that you deposit laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see http://journals.plos.org/plospathogens/s/submission-guidelines#loc-materials-and-methods

Revision 2

Attachments
Attachment
Submitted filename: Point_to_Point_Gdh2.pdf
Decision Letter - Scott G. Filler, Editor, Damian J Krysan, Editor

Dear Dr. Ljungdahl,

Thank you very much for submitting your manuscript "Glutamate dehydrogenase (Gdh2)-dependent alkalization is dispensable for escape from macrophages and virulence of Candida albicans" for consideration at PLOS Pathogens. As with all papers reviewed by the journal, your manuscript was reviewed by members of the editorial board and by several independent reviewers. The reviewers appreciated the attention to an important topic. Based on the reviews, we are likely to accept this manuscript for publication, providing that you modify the manuscript according to the review recommendations.

Thank you for your careful and response to previous reviews. The new data on intracellular/macrophage pH have strengthened the manuscript and both reviewers are very positive. As you will note, Reviewer 1 has a couple of minor textural suggestions that I also think should be addressed. I think this is an important and complex problem that as, you note in the discussion, has a number of interesting and outstanding questions. I appreciated your discussion of potential reasons for conflicting data and models. In the interest of collegiality and progress in the field this is very important.

Please prepare and submit your revised manuscript within 30 days. If you anticipate any delay, please let us know the expected resubmission date by replying to this email. 

When you are ready to resubmit, please upload the following:

[1] A letter containing a detailed list of your responses to all review comments, and a description of the changes you have made in the manuscript. 

Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out

[2] Two versions of the revised manuscript: one with either highlights or tracked changes denoting where the text has been changed; the other a clean version (uploaded as the manuscript file).

Important additional instructions are given below your reviewer comments.

Thank you again for your submission to our journal. We hope that our editorial process has been constructive so far, and we welcome your feedback at any time. Please don't hesitate to contact us if you have any questions or comments.

Sincerely,

Damian J Krysan, MD PhD

Associate Editor

PLOS Pathogens

Scott Filler

Section Editor

PLOS Pathogens

Kasturi Haldar

Editor-in-Chief

PLOS Pathogens

orcid.org/0000-0001-5065-158X

Michael Malim

Editor-in-Chief

PLOS Pathogens

orcid.org/0000-0002-7699-2064

***********************

Reviewer Comments (if any, and for reference):

Reviewer's Responses to Questions

Part I - Summary

Please use this section to discuss strengths/weaknesses of study, novelty/significance, general execution and scholarship.

Reviewer #1: A major improvement was the inclusion of new data demonstrating the acidification of the lysosomes following C. albicans phagocytosis. The authors used a new approach of crosslinking a pH sensitive dye to the cells (pHrodo). A strength of this approach is that the fluorescence increases as the ambient pH gets lower. This avoids concerns that factors such as photobleaching could interfere.

However, there are some minor issues with the manuscript that need to be addressed. In regard to the comments below concerning Gdh2-GFP, the authors should be clearer about what are the limits of their conclusions regarding the levels of Gdh2-GFP. Also, they should explain why in some experiments Gdh2-GFP does not appear to localize to the mitochondria.

Reviewer #3: The authors have preformed the additional requested studies and addressed the comments of the reviewers.

**********

Part II – Major Issues: Key Experiments Required for Acceptance

Please use this section to detail the key new experiments or modifications of existing experiments that should be absolutely required to validate study conclusions.

Generally, there should be no more than 3 such required experiments or major modifications for a "Major Revision" recommendation. If more than 3 experiments are necessary to validate the study conclusions, then you are encouraged to recommend "Reject".

Reviewer #1: (No Response)

Reviewer #3: (No Response)

**********

Part III – Minor Issues: Editorial and Data Presentation Modifications

Please use this section for editorial suggestions as well as relatively minor modifications of existing data that would enhance clarity.

Reviewer #1: 1. Lines 380-381,393, 514 and 1048. The manuscript refers to a supplemental video SV12, but SV12 was not included.

2. The authors complemented the gdh2-/- strain by reintroducing a DNA fragment carrying the wild type GDH2 gene. Was it marked in any way to distinguish it from a pre-existing gdh2-/GDH2 strain?

3. Fig. 3A. The Gdh2-GFP signal goes up, but it does not look mitochondrial

4. Fig S6. The Gdh2-GFP signal goes up, but it does not look mitochondrial

5. Fig. 4B and 4C. Not clear that the Gdh2-GFP signal is increasing. How was this quantified.

6. SV2 Not clear that the Gdh2-GFP is increasing until the hyphae break out of the macrophage. How was this quantified?

Reviewer #3: (No Response)

**********

PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #3: No

Figure Files:

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org.

Data Requirements:

Please note that, as a condition of publication, PLOS' data policy requires that you make available all data used to draw the conclusions outlined in your manuscript. Data must be deposited in an appropriate repository, included within the body of the manuscript, or uploaded as supporting information. This includes all numerical values that were used to generate graphs, histograms etc.. For an example see here: http://www.plosbiology.org/article/info%3Adoi%2F10.1371%2Fjournal.pbio.1001908#s5.

Reproducibility:

To enhance the reproducibility of your results, PLOS recommends that you deposit laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see http://journals.plos.org/plospathogens/s/submission-guidelines#loc-materials-and-methods

Revision 3

Attachments
Attachment
Submitted filename: Points_Reviewers comments_200808.pdf
Decision Letter - Scott G. Filler, Editor, Damian J Krysan, Editor

Dear Dr. Ljungdahl,

We are pleased to inform you that your manuscript 'Glutamate dehydrogenase (Gdh2)-dependent alkalization is dispensable for escape from macrophages and virulence of Candida albicans' has been provisionally accepted for publication in PLOS Pathogens. Thank you for your response to the reviews and congratulations on a nice piece of work.

Before your manuscript can be formally accepted you will need to complete some formatting changes, which you will receive in a follow up email. A member of our team will be in touch with a set of requests.

Please note that your manuscript will not be scheduled for publication until you have made the required changes, so a swift response is appreciated.

IMPORTANT: The editorial review process is now complete. PLOS will only permit corrections to spelling, formatting or significant scientific errors from this point onwards. Requests for major changes, or any which affect the scientific understanding of your work, will cause delays to the publication date of your manuscript.

Should you, your institution's press office or the journal office choose to press release your paper, you will automatically be opted out of early publication. We ask that you notify us now if you or your institution is planning to press release the article. All press must be co-ordinated with PLOS.

Thank you again for supporting Open Access publishing; we are looking forward to publishing your work in PLOS Pathogens.

Best regards,

Damian J Krysan, MD PhD

Associate Editor

PLOS Pathogens

Scott Filler

Section Editor

PLOS Pathogens

Kasturi Haldar

Editor-in-Chief

PLOS Pathogens

orcid.org/0000-0001-5065-158X

Michael Malim

Editor-in-Chief

PLOS Pathogens

orcid.org/0000-0002-7699-2064

***********************************************************

Reviewer Comments (if any, and for reference):

Formally Accepted
Acceptance Letter - Scott G. Filler, Editor, Damian J Krysan, Editor

Dear Professor Ljungdahl,

We are delighted to inform you that your manuscript, "Glutamate dehydrogenase (Gdh2)-dependent alkalization is dispensable for escape from macrophages and virulence of Candida albicans," has been formally accepted for publication in PLOS Pathogens.

We have now passed your article onto the PLOS Production Department who will complete the rest of the pre-publication process. All authors will receive a confirmation email upon publication.

The corresponding author will soon be receiving a typeset proof for review, to ensure errors have not been introduced during production. Please review the PDF proof of your manuscript carefully, as this is the last chance to correct any scientific or type-setting errors. Please note that major changes, or those which affect the scientific understanding of the work, will likely cause delays to the publication date of your manuscript. Note: Proofs for Front Matter articles (Pearls, Reviews, Opinions, etc...) are generated on a different schedule and may not be made available as quickly.

Soon after your final files are uploaded, the early version of your manuscript, if you opted to have an early version of your article, will be published online. The date of the early version will be your article's publication date. The final article will be published to the same URL, and all versions of the paper will be accessible to readers.

Thank you again for supporting open-access publishing; we are looking forward to publishing your work in PLOS Pathogens.

Best regards,

Kasturi Haldar

Editor-in-Chief

PLOS Pathogens

orcid.org/0000-0001-5065-158X

Michael Malim

Editor-in-Chief

PLOS Pathogens

orcid.org/0000-0002-7699-2064

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .